TSPO and metabolic dysfunction-associated steatotic liver disease: Overall, Tspo deficiency exacerbates the advancement of SS by enhancing CD36‐mediated FFA uptake, elevating AcCoA levels, compromising mitochondrial function and impairing autophagy during the early stages of MASLD.